Mapping ICD-10 to ICCC-3 for childhood cancer classification using cancer incidence in five continents (CI5) data
Year: 2026
Type: article
Abstract: Global childhood and adolescent cancer burden estimation is limited by inconsistent diagnostic classification systems. ICCC‑3 is the benchmark for pediatric cancer research, but large registries mainly use ICD‑10, which cannot be directly matched to ICCC‑3. A unified mapping framework is required to accurately quantify disease burden and enable cross‑database data comparison. We used pediatric cancer incidence data from the US registries in CI5 Volume XII, which provides dual coding in ICD-10 and ICCC-3. We performed direct mapping to 12 main groups of the ICCC-3. In parallel, an ICD-O-3-derived ICD-10-to-ICCC-3 crosswalk table was developed exclusively for lymphoid and hematopoietic neoplasms. We identified 77,236 pediatric cancer cases coded in ICD-10 and 77,152 cases coded in ICCC-3. Near-unity concordance (CR ≈ 1.00) was observed for retinoblastoma, brain and CNS tumors, renal tumors, and hepatic tumors. Over-mapping was noted for other epithelial neoplasms/melanomas (CR = 1.29), bone tumors (CR = 1.11), and leukemias (CR = 1.07), while under-mapping occurred for neuroblastomas (CR = 0.67), germ cell tumors (CR = 0.74), soft tissue sarcomas (CR = 0.85), lymphomas (CR = 0.88), and unspecified malignant neoplasms (CR = 0.47). Although forward mapping rules from ICCC-3/ICD-O to ICD-10 are available, no systematic reverse mapping from ICD-10 to ICCC-3 has been established. Here we provide the first such systematic mapping. Overall mapping concordance was variable across tumor groups, attributable to insufficient morphological detail within ICD-10. For lymphoid and hematopoietic neoplasms, we generated an ICD-O-3-derived crosswalk table for potential subgroup classification, though case-level subgroup mapping was not performed in the present analysis. Not applicable.
Source: BMC Pediatrics
Authors: Jiaxing Liu, Xinghua Sun, Manli Sun, Huan Yang
Institution: Heilongjiang University of Chinese Medicine
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7202096020
